Purchase Order 75N95024P00191

Award Date 3/19/24
Potential Completion Date 3/18/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Baltimore, MD 21224, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH (ABX GMBH) has been awarded a firm fixed-price purchase order contract valued at $20,000 by the National Institutes of Health's National Institute on Drug Abuse. Under this contract, ABX GMBH will provide reagents and synthesis cassettes for F-DOPA to support the NIH's biomedical research efforts. Place of performance will be in Baltimore, Maryland over a one year period from August 2023 through August 2024. No...
The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $250,000.00 firm-fixed-price purchase order to the Baruch S. Blumberg Institute, a non-profit organization and foundation, for a project related to the "NATURAL PRODUCTS EXTRACTS LIBRARY" program. The award did not use a set-aside. The place of performance is Doylestown, Pennsylvania, and the award date was August 14, 2017, with a completion date of September 14, 2017.
<p>The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse awarded a $104,870.00 firm fixed price purchase order contract to Life Chemicals Inc., a for-profit organization, for services to be performed in Canada. The contract was not set aside for any special designation. The award was made on September 7, 2017, with a completion date of November 1, 2017.</p>
This is a $156,000.00 firm fixed price purchase order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Oncolead GMBH &amp; CO. KG, a for-profit limited liability company located in Germany. The contract does not have a set-aside designation and was awarded on September 23, 2015 with a period of performance ending on September 30, 2016. As NIDA is the agency responsible for advancing research on drug use and addiction, this contract is likely supporting the...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a firm fixed price purchase order valued at fourteen thousand three hundred ninety-five dollars and fifteen cents ($14,395.15) to FEI Company Materials And Stuctural Analysis Division Division. The contract period is from August 17, 2023 to January 17, 2024 and calls for delivery of CATALOG # : QUOTE#122299 / PREF TECNAI12BT / D347 / F1040254. Place of performance will be in...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $23,656.84 firm fixed price purchase order to Proteinsimple, a division of Bio-Techne Corporation. The contract is to provide Lindsay Kryszak with a custom SimplePlex cartridge kit for 32 samples to support protein analysis. Performance will occur in Baltimore, Maryland over a one year period from December 2023 through December 2024. No subcontractors or set aside designations...
<p>The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Firm Fixed Price Purchase Order contract to Aushon Biosystems, Inc., a for-profit organization, for $124,879.00. The contract has a completion date of September 29, 2018 and was awarded on September 22, 2017. The place of performance is Billerica, MA 01821, USA. This contract does not have a set-aside designation.</p>
The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $15,668.80 firm fixed price purchase order to Med Associates, Inc. for RAT BEHAVIOR BOX PARTS. The prime contractor, Med Associates, Inc. doing business as Med Associates Inc., will deliver the rat behavior box parts to support research being conducted at the place of performance in Baltimore, Maryland. The purchase order has a period of performance from July 26, 2023 through...
This federal contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Drug Abuse to Edition Eight, LLC, a for-profit limited liability company. The $134,508.00 firm fixed-price purchase order contract has a completion date of October 5, 2017. No set-aside was used for this award. The place of performance is Potomac, Maryland. Based on the information provided, this contract appears to be for products or services related...
This federal contract award, HHSN271201500631P, was made by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services (HHS), to Cisbio US, Inc., a foreign-owned for-profit company. The $84,700 firm-fixed-price purchase order contract is for the provision of assay kits and reagents, including those used to detect biomarkers related to disease research, as well as cell lines and collagen reagents. The contract has a total small business...

The U.S. Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $11,210.00 Firm Fixed Price Purchase Order to ABX Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GMBH, a foreign-owned for-profit limited liability company. The contract, which does not have a set-aside designation, is for the delivery of custom order quantities of the SDM-8 tin precursor compound in 200 mg, 10 mg, and 5 mg vials. The place of performance is Baltimore, Maryland, and the completion date is March 18, 2025.

Generated 3/27/24, 10:52 AM